Oxidative Medicine and Cellular Longevity

Table of Contents: 2022

  • Oxidative Medicine and Cellular Longevity -
  • Special Issue
  • Volume 2022
  • - Article ID 2930310
  • - Research Article

Methylation Pattern Mediated by m6A Regulator and Tumor Microenvironment Invasion in Lung Adenocarcinoma

Feng Jiang | Yifang Hu | ... | Chuyan Wu
  • Oxidative Medicine and Cellular Longevity -
  • Special Issue
  • Volume 2022
  • - Article ID 1733834
  • - Research Article

Calycosin Alleviates Doxorubicin-Induced Cardiotoxicity and Pyroptosis by Inhibiting NLRP3 Inflammasome Activation

Lei Zhang | Cundong Fan | ... | Yi-Tao Xue
  • Oxidative Medicine and Cellular Longevity -
  • Special Issue
  • - Volume 2022
  • - Article ID 8854457
  • - Research Article

Methylglyoxal Scavengers Attenuate Angiogenesis Dysfunction Induced by Methylglyoxal and Oxygen-Glucose Deprivation

Wei Chen | Wenhui Huang | ... | Keshen Li
  • Oxidative Medicine and Cellular Longevity -
  • Special Issue
  • - Volume 2022
  • - Article ID 5583512
  • - Research Article

Rosiglitazone Ameliorates Spinal Cord Injury via Inhibiting Mitophagy and Inflammation of Neural Stem Cells

Qingqi Meng | Zhiteng Chen | ... | Haifeng Zhang
  • Oxidative Medicine and Cellular Longevity -
  • Special Issue
  • Volume 2022
  • - Article ID 1458143
  • - Review Article

The Potential Mechanisms by which Artemisinin and Its Derivatives Induce Ferroptosis in the Treatment of Cancer

Yingying Hu | Nan Guo | ... | Xiang Li
  • Oxidative Medicine and Cellular Longevity -
  • Special Issue
  • Volume 2022
  • - Article ID 9911982
  • - Research Article

LncRNA-XIST Promotes Proliferation and Migration in ox-LDL Stimulated Vascular Smooth Muscle Cells through miR-539-5p/SPP1 Axis

Yi Zhang | Yong Tang | Jianhua Yan
  • Oxidative Medicine and Cellular Longevity -
  • Special Issue
  • Volume 2022
  • - Article ID 4328116
  • - Research Article

Lipopolysaccharide Enhances Genotoxicity by Activating GADD45G and NF-κB in Human Corneal Epithelial Cells

Ramachandran Samivel | Umadevi Subramanian | ... | Saeed Akhtar
  • Oxidative Medicine and Cellular Longevity -
  • Special Issue
  • Volume 2022
  • - Article ID 6037303
  • - Research Article

Resveratrol Treats UVB-Induced Photoaging by Anti-MMP Expression, through Anti-Inflammatory, Antioxidant, and Antiapoptotic Properties, and Treats Photoaging by Upregulating VEGF-B Expression

Baining Cui | Yan Wang | ... | Zheng Li
  • Oxidative Medicine and Cellular Longevity -
  • Special Issue
  • - Volume 2022
  • - Article ID 3235524
  • - Review Article

Role of NETosis in Central Nervous System Injury

Yituo Chen | Haojie Zhang | ... | Kailiang Zhou
  • Oxidative Medicine and Cellular Longevity -
  • Special Issue
  • - Volume 2022
  • - Article ID 2235335
  • - Research Article

Nanoscale Modification of Titanium Implants Improves Behaviors of Bone Mesenchymal Stem Cells and Osteogenesis In Vivo

Huangdi Li | Jinghui Huang | ... | Jun Zuo
  • Oxidative Medicine and Cellular Longevity -
  • Special Issue
  • - Volume 2022
  • - Article ID 2792348
  • - Research Article

Hydrogen Sulfide Attenuates the Cognitive Dysfunction in Parkinson’s Disease Rats via Promoting Hippocampal Microglia M2 Polarization by Enhancement of Hippocampal Warburg Effect

Qing Tian | Hui-Ling Tang | ... | Xiao-Qing Tang
  • Oxidative Medicine and Cellular Longevity -
  • Special Issue
  • Volume 2022
  • - Article ID 3617775
  • - Research Article

Establishment of a Prognostic Prediction and Drug Selection Model for Patients with Clear Cell Renal Cell Carcinoma by Multiomics Data Analysis

Aimin Jiang | Yewei Bao | ... | Linhui Wang
Oxidative Medicine and Cellular Longevity
 Journal metrics
See full report
Acceptance rate8%
Submission to final decision133 days
Acceptance to publication34 days
CiteScore10.100
Journal Citation Indicator-
Impact Factor-
 Submit Check your manuscript for errors before submitting

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.